Sonnet BioTherapeutics Holdings Financial Overview
Sonnet BioTherapeutics Holdings's market cap is currently $22.65M. The company's EPS TTM is $-0.952; its P/E ratio is -0.39; Sonnet BioTherapeutics Holdings is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
